Vivo Opportunity Fund, L.P.
Insider CIK 1726403 · SRRA 10% owner · BOLT 10% owner · CRNX 10% owner · ALXO 10% owner · TERN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 800,000 | $27.00 | $21.60M | 2,735,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 1,455,384 | $13.20 | $19.21M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 324,740 | $13.20 | $4.29M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 75,749 | $13.20 | $999.9K | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 107,164 | $13.20 | $1.41M | 431,947 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 24,996 | $13.20 | $329.9K | 161,712 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 480,277 | $13.20 | $6.34M | 1,935,853 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 364,138 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 98,484 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 713,203 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion deriv | 2021-02-09 | 2021-02-09 | 50,282 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 944,056 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 17,711 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 472,296 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 1,092,080 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 5,655 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 47,718 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 43,901 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 150,802 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise deriv | 2021-02-09 | 2021-02-09 | 40,953 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 345,568 | — | $0 | 0 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 317,922 | — | $0 | 0 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 357,353 | $17.00 | $6.08M | 357,353 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 14,275 | $17.00 | $242.7K | 281,223 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 266,948 | — | $0 | 266,948 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | C Conversion | 2021-02-09 | 2021-02-09 | 1,933,185 | — | $0 | 1,933,185 | SEC↗ |
| TERN Terns Pharmaceuticals, Inc | P Buy | 2021-02-09 | 2021-02-09 | 103,372 | $17.00 | $1.76M | 2,036,557 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 144 | $20.00 | $2.9K | 1,821,483 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 40,953 | $0.07 | $2.9K | 1,821,627 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 345,568 | — | $0 | 1,780,674 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 317,922 | — | $0 | 1,435,106 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,092,080 | — | $0 | 1,117,184 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 62 | $20.00 | $1.2K | 1,448,286 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 17,711 | $0.07 | $1.2K | 1,448,348 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 472,296 | — | $0 | 1,430,637 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 175,733 | $20.00 | $3.51M | 1,997,216 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 150,802 | — | $0 | 154,268 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 43,901 | — | $0 | 198,169 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 47,718 | — | $0 | 245,887 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | X Exercise | 2021-02-09 | 2021-02-09 | 5,655 | $0.07 | $396 | 251,542 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 20 | $20.00 | $400 | 251,522 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 24,267 | $20.00 | $485.3K | 275,789 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | P Buy | 2021-02-09 | 2021-02-09 | 150,000 | $20.00 | $3.00M | 150,000 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 944,056 | — | $0 | 958,341 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 3,158,851 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 185,526 | $19.00 | $3.52M | 185,526 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 3,245,048 | — | $0 | 4,034,522 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 789,474 | $19.00 | $15.00M | 789,474 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 48 | $19.50 | $936 | 375,880 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 133 | $19.50 | $2.6K | 168,165 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-03-09 | 2020-03-11 | 347 | $19.50 | $6.8K | 2,722,045 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 200 | $21.40 | $4.3K | 375,928 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 5,904 | $21.40 | $126.3K | 168,298 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-10 | 2020-02-11 | 1,451 | $21.40 | $31.1K | 2,722,392 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 4,614 | $22.00 | $101.5K | 174,202 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 157 | $22.00 | $3.5K | 376,128 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-07 | 2020-02-11 | 1,134 | $22.00 | $24.9K | 2,723,843 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 10,519 | $22.80 | $239.8K | 178,816 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 2,584 | $22.80 | $58.9K | 2,724,977 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-02-04 | 2020-02-06 | 357 | $22.80 | $8.1K | 376,285 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 143 | $21.70 | $3.1K | 376,642 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 4,220 | $21.70 | $91.6K | 189,335 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-31 | 2020-01-31 | 1,037 | $21.70 | $22.5K | 2,727,561 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 5,940 | $22.10 | $131.3K | 193,555 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 201 | $22.10 | $4.4K | 376,785 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-30 | 2020-01-31 | 1,459 | $22.10 | $32.2K | 2,728,598 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 1,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 4,287 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,213 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,455,576 | — | $0 | 1,455,576 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 324,783 | — | $0 | 324,783 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 75,759 | — | $0 | 136,715 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 2,673 | $22.20 | $59.3K | 2,730,057 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 369 | $22.20 | $8.2K | 376,986 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2020-01-29 | 2020-01-31 | 10,878 | $22.20 | $241.5K | 199,495 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 40,407 | $22.25 | $899.1K | 377,355 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 292,609 | $22.25 | $6.51M | 2,732,730 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2019-03-20 | 2019-03-25 | 83,984 | $22.25 | $1.87M | 210,373 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 8,424,416 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 187,648 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 1,358,903 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion deriv | 2018-07-20 | 2018-07-20 | 1,163,311 | — | $0 | 0 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 57,035 | — | $0 | 410,625 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 413,040 | — | $0 | 2,973,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 51,686 | $17.00 | $878.7K | 3,025,339 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 7,137 | $17.00 | $121.3K | 417,762 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 141,177 | $17.00 | $2.40M | 141,177 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | P Buy | 2018-07-20 | 2018-07-20 | 153,180 | $20.73 | $3.18M | 294,357 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 2,560,613 | — | $0 | 2,560,613 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | C Conversion | 2018-07-20 | 2018-07-20 | 353,590 | — | $0 | 353,590 | SEC↗ |